CARsgen, Moderna partner to assess CT041 and mRNA cancer vaccine combination
The partnership intends to test satricabtagene autoleucel in combination with Claudin18.2 mRNA cancer vaccine through preclinical research and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Aug 23
The partnership intends to test satricabtagene autoleucel in combination with Claudin18.2 mRNA cancer vaccine through preclinical research and…
21 Aug 23
The approval was based on positive results from the DELIVER Phase 3 trial in which Forxiga met its…
21 Aug 23
FDA granted the approval based on the data from the KINECT-HD Phase 3 study and the ongoing KINECT-HD2…
21 Aug 23
Teclistamab, the first BCMA-targeting bispecific antibody to receive approval in Europe, maintained deep and durable responses, with reduced…
21 Aug 23
he funding will accelerate the clinical development of AST-004, a highly promising therapeutic candidate aimed at treating a…
18 Aug 23
According to Moderna, these findings imply that the updated Covid-19 vaccine can successfully combat the Covid-19 variations that…
18 Aug 23
This decision was supported by newly released data from a Phase 2 dose discovery study in overweight or…
18 Aug 23
Lupin has been actively marketing Ondero and Ondero Met in the Indian market since 2015 through a co-marketing…
18 Aug 23
Ahead of the fall and winter RSV season, AREXVY is now widely available in major retail pharmacies and…
18 Aug 23
The spotlight is poised to shine on India as the G20 Health Minister's Meeting, under India's G20 Presidency, kicks off…